Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2025 Feb 15;405(10478):547-559.
doi: 10.1016/S0140-6736(25)00047-9. Epub 2025 Jan 29.

Epidemiological and clinical features of mpox during the clade Ib outbreak in South Kivu, Democratic Republic of the Congo: a prospective cohort study

Affiliations
Observational Study

Epidemiological and clinical features of mpox during the clade Ib outbreak in South Kivu, Democratic Republic of the Congo: a prospective cohort study

Isabel Brosius et al. Lancet. .

Abstract

Background: Clade Ib, a new strain of clade I monkeypox virus, emerged in eastern DR Congo, sparking an international outbreak. Comprehensive studies are needed to assess its transmission dynamics and clinical presentation.

Methods: We did a prospective observational cohort study at Kamituga General Hospital in South Kivu, DR Congo, between May 2 and Oct 9, 2024. Sociodemographic, exposure, and clinical data were collected from mpox-suspected cases. Cases were confirmed by Xpert Mpox PCR and followed through hospitalisation and on days 29 and 59 after diagnosis.

Findings: Of the 510 suspected cases included, 407 (80%) tested positive via PCR. Among the 407 confirmed cases, 196 (48%) were women. Age distribution was bimodal, with 58 (14%) children younger than 5 years, and 267 (66%) individuals aged 15-34 years. Most cases (237 [58%] of 406) reported contact with a suspected or confirmed mpox case; primarily colleagues, spouses or sexual partners in adults, and parents or siblings in children. Self-reported comorbidities were rare (18 [5%] of 400), including 6 (2%) people infected with HIV. Prodromal symptoms were present in 331 (88%) of 375 patients, active skin lesions in 394 (97%) of 407 patients, mucosal lesions in 324 (82%) of 394 patients, and lymphadenopathy in 288 (73%) of 394 patients. In adults, 280 (89%) of 314 had genital skin lesions and mean lesion density was highest in the genital area. In contrast, only 35 (42%) of 84 children had genital lesions, as part of a more uniform rash. Among 403 hospitalised patients, two (<1%) deaths occurred. Among 296 patients with detailed hospital follow-up, complications were primarily genito-urinary (169 [57%]) or cutaneous (121 [41%]). Four (67%) of six pregnant women with recorded outcome had adverse pregnancy outcomes. On days 29 and 59, few sequelae were reported other than scars.

Interpretation: Clade Ib infections in Kamituga showed distinct clinical patterns compared with clade Ia outbreaks elsewhere in the country and the global clade IIb outbreak. In adults, the disease primarily affected the genito-urinary system, compatible with sexual transmission, whereas children mostly manifested extragenital lesions. These findings highlight the need for updated case definitions and targeted public health interventions to address evolving transmission dynamics and mitigate risks for vulnerable groups, including pregnant women and young children.

Funding: European & Developing Countries Clinical Trials Partnership (EDCTP2 and EDCTP3); Belgian Directorate-General Development Cooperation and Humanitarian Aid; Research Foundation-Flanders.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests LL has received institutional consultancy fees from BioNtech and institutional research funding from Sanofi; both not relevant for this work. JK has provided expert witness reports for the Treasury Board of Canada not relevant to this work. JK has also received mpox research funding from the Canadian Institutes of Health Research and the International Development Research Centre in open funding competitions. All other authors declare no competing interests.

Figures

Figure 1
Figure 1. Demographics, Clinical Presentation and Evolution of Clade Ib mpox, South-Kivu, DRC
(A) Age and sex distribution of confirmed mpox participants, (B) Body map indicating the proportion of participants with lesions in a given body region at inclusion for adults (>= 15 years) and children 0-14 years. (C) Body map indicating the mean density of skin lesions per body region at inclusion for individuals of 15 years old and above, and children aged 0 to 14 years old, expressed as number of lesions (n) per percentage of total body surface area (TBSA) according to a modified Lund-Browder chart for estimated TBSA. (D) Body map indicating the proportion of participants with scars per body region on day 59 after diagnosis for adults (>= 15 years) and children 0-14 years. (E) Kaplan-Meier estimates for time from onset of active lesions to resolution, with 95% confidence interval. (F) Kaplan-Meier estimates for time from onset of symptoms to resolution of all symptoms, with 95% confidence Interval.
Figure 2
Figure 2. Clinical images of skin and genital mpox lesions
(A) Papular, umbilicated and ulcerated lesions on the hand. (B) Umbilicated lesions with high lesion density on the head and neck. (C) Infant with generalized lesion distribution. (D) Infant with umbilicated and confluent lesions in the face. (E) Genital mpox complicated with Fournier’s gangrene in an adult male. (F) Ulcerated and necrotic lesions on the penis and upper thigh in adult male. (G) Complex skin and genital mucosal lesion with labial edema, surrounded by papules and umbilicated genital skin lesions in adult female. (H) Complex genital skin lesion in adult female.

Comment in

References

    1. Mitjà O, Ogoina D, Titanji BK, Galvan C, Muyembe JJ, Marks M, et al. Monkeypox. The Lancet. 2023 Jan 7;401(10370):60–74. doi: 10.1016/S0140-6736(22)02075-X. - DOI - PMC - PubMed
    1. 2022-24 Mpox (Monkeypox) Outbreak: Global Trends. [cited 2024 Sep 24]. [Internet] Available from: https://worldhealthorg.shinyapps.io/mpx_global/#43_Case_profile_(overall)
    1. Yinka-Ogunleye A, Aruna O, Dalhat M, Ogoina D, McCollum A, Disu Y, et al. Outbreak of human monkeypox in Nigeria in 2017–18: a clinical and epidemiological report. Lancet Infect Dis. 2019 Aug 1;19(8):872. doi: 10.1016/S1473-3099(19)30294-4. - DOI - PMC - PubMed
    1. Thornhill JP, Barkati S, Walmsley S, Rockstroh J, Antinori A, Harrison LB, et al. Monkeypox Virus Infection in Humans across 16 Countries - April-June 2022. N Engl J Med. 2022 Aug 25;387(8):679–91. - PubMed
    1. Bangwen E, Diavita R, De Vos E, Hasivirwe Vakaniaki E, Nundu SS, Mutombo A, et al. Mpox in the Democratic Republic of Congo: Analysis of National Epidemiological and Laboratory Surveillance Data, 2010 - 2023. [cited 2024 Oct 23];2024 Available from: https://papers.ssrn.com/abstract=4954317.

Publication types

MeSH terms